Steqeyma 130mg / 26mL

Steqeyma 130mg / 26mL is a medicine authorised by Swissmedic under authorisation number 70002. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 April 2025 and the authorisation is limited until 23 April 2030. ATC code L04AC05 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70002
  • ATC L04AC05
  • Biotechnological medicines
Authorisation data
Authorisation number70002
NameSteqeyma 130mg / 26mL
Full nameSteqeyma 130mg / 26mL, solution à diluer pour perfusion
Authorisation holderIQONE HEALTHCARE SWITZERLAND SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC05
First authorisation24 April 2025
Authorisation validity23 April 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Steqeyma 130mg / 26mL, solution à diluer pour perfusionB24 April 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Steqeyma 130mg / 26mL authorised in Switzerland?

Yes. Steqeyma 130mg / 26mL is authorised by Swissmedic under authorisation number 70002, data as of 01 September 2026. The authorisation is limited until 23 April 2030.

Which dispensing category does Steqeyma 130mg / 26mL have?

Steqeyma 130mg / 26mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Steqeyma 130mg / 26mL?

The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com